An Open-Label, Randomised, Single-Dose, Parallel-Group Study to Compare the Pharmacokinetic Characteristics, Safety and Tolerability of Two Formulations of Lamotrigine in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders; Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 04 Jan 2007 New trial record.